Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Open in API
Filings indexed 965 across all filing types
Latest filing 2021-02-07 Capital/Financing Update
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
MEDIVIR PROPOSES DIRECTED ISSUE OF APPROXIMATELY SEK 28 MILLION TO THE COMPANY’S EXISTING SPECIALIST INVESTOR LINC
Capital/Financing Update Classification · 98% confidence The document is titled "MEDIVIR PROPOSES DIRECTED ISSUE OF APPROXIMATELY SEK 28 MILLION TO THE COMPANY'S EXISTING SPECIALIST INVESTOR LINC" and discusses a proposal for a directed share issue to a related party (LINC, controlled by a board member) requiring shareholder approval at an extraordinary general meeting. This action involves changing the capital structure (issuing new shares) and is a specific corporate financing event. This aligns directly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory announcement (RNS), as it details a specific financing transaction.
2021-02-07 English
MEDIVIR FÖRESLÅR RIKTAD NYEMISSION OM CIRKA 28 MSEK TILL BOLAGETS BEFINTLIGA SPECIALISTINVESTERARE LINC
Capital/Financing Update Classification · 98% confidence The document is a press release announcing a proposed directed new share issue (nyemission) of approximately 28 MSEK to a specific existing specialist investor (LINC, controlled by a board member). This action involves issuing new shares and is explicitly related to the company's capital structure and fundraising efforts. This directly aligns with the definition of 'Capital/Financing Update' (CAP). Although it mentions an Extraordinary General Meeting (EGM) to approve the transaction, the core subject is the financing activity itself, not the voting results (DVA) or the AGM materials (AGM-R). It is not a full annual report (10-K), an interim report (IR), or a general regulatory filing (RNS), as it details a specific corporate finance event.
2021-02-07 Swedish
PRELIMINARY OUTCOME IN MEDIVIR’S RIGHTS ISSUE – OVERSUBSCRIBED BY 93.5 PER CENT
Capital/Financing Update Classification · 98% confidence The document is titled "PRELIMINARY OUTCOME IN MEDIVIR'S RIGHTS ISSUE – OVERSUBSCRIBED BY 93.5 PER CENT". It discusses the results of a rights issue, the intention to exercise an over-allotment option, the total proceeds expected (SEK 195 million), and provides a preliminary timetable for share allotment and trading. This content directly relates to a company fundraising or capital structure change event, specifically the completion and results of a rights issue. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it is a press release announcing the results, the core subject matter is the financing activity itself, making CAP more specific than a general RPA or ER.
2021-02-05 English
PRELIMINÄRT UTFALL I MEDIVIRS FÖRETRÄDESEMISSION – ÖVERTECKNAD MED 93,5 PROCENT
Capital/Financing Update Classification · 98% confidence The document is a press release from Medivir AB, dated February 5, 2021, announcing the 'PRELIMINARY OUTCOME OF MEDIVIR'S RIGHTS ISSUE – OVER-SUBSCRIBED BY 93.5 PERCENT'. The text details the subscription results of a rights issue (företrädesemission) intended to raise approximately 170 MSEK, plus an over-allotment option (övertilldelningsoption) to raise an additional 25 MSEK, totaling about 195 MSEK. This clearly relates to the company's fundraising and capital structure activities. This fits the definition of 'Capital/Financing Update' (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). Since it is a detailed announcement about a specific financing event, CAP is the most appropriate classification.
2021-02-05 Swedish
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 98% confidence The document details a change in shareholding and voting rights for a specific instrument (Aktier) involving an Issuer (Medivir Aktiebolag) and a Holder (Avanza Bank Holding AB). It explicitly states the 'Percentage' of voting rights held after a transaction on 20/01/2021, noting that 'Flaggning sker för passerat tröskelvärde beträffande det aggregerade innehavet' (Flagging occurs for crossing the threshold regarding the aggregate holding). This structure—reporting changes in ownership that cross regulatory thresholds (like 5%, 10%, etc.)—is characteristic of Major Shareholding Notifications. This aligns perfectly with the definition for 'Major Shareholding Notification' (Code: MRQ). The document is not an Annual Report (10-K), Earnings Release (ER), or a general regulatory filing (RNS), but a specific disclosure about ownership change.
2021-01-21 English
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific instrument (Aktier/Shares) involving an entity (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension) and explicitly states the 'Reason for major shareholding notification Sell'. It provides 'Before the transaction' and 'After the transaction' data, including the resulting percentage (9.7%) and number of shares (2,357,127). This structure is characteristic of a notification regarding a change in significant ownership thresholds. Based on the provided definitions, this aligns perfectly with the Major Shareholding Notification category.
2021-01-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.